7:55 — 8:00 am
Paul Ritch, MD
Medical College of Wisconsin
8:00 — 8:40 am
Smoking Cessation and Tobacco Control
Douglas Jorenby, PhD
University of Wisconsin
Director of Clinical Services for UW-CTRI since 1992, Dr.Jorenby is responsible for clinical activities at the Center. He is a clinical psychologist and professor of medicine at the University of Wisconsin-Madison Medical School, where he conducts a variety of research, clinical, and professional education activities.
Dr. Jorenby has served as Principal Investigator or Co-Principal Investigator on a number of studies involving the efficacy of various behavioral and pharmacologic treatments for tobacco dependence. His current research involves optimization of new and existing treatments for individuals through predictive modeling. He has also published research on treatment for women.
Jorenby received his Ph.D. and completed a postdoctoral fellowship in Preventive Oncology at the University of Wisconsin-Madison.
8:40 — 9:20 am
Grace Dy, MD
Dr. Grace Dy is a medical oncologist at Roswell Park Comprehensive Cancer Center, where she is chief of Thoracic Oncology. She is an Associate Professor of Medicine at the Jacobs School of Medicine and Biomedical Sciences, University at Buffalo. Her areas of expertise are lung cancer, mesothelioma, and thymic malignancies. Her special interests are Phase 1 clinical trials and novel targets for lung cancer therapy.
Dr. Dy received her MD at the University of Santo Tomas, Manila, Philippines. She completed her residency and Fellowship at the Mayo Clinic College of Medicine in Rochester, MN. She is Board Certified in Hematolgy, Medical Oncology and internal Medicine.
9:20 — 10:00 am
Corey Langer, MD
University of Pennsylvania
Dr. Corey Langer is a Professor of Medicine at the Hospital of the University of Pennsylvania, with clinical expertise in lung and head and neck cancer. He received his medical degree from the Boston University School of Medicine and completed fellowships at Penn Presbyterian Medical Center and Fox Chase Cancer Center. Dr. Langer has contributed numerous articles (>200) and abstracts (>250) to the medical literature. His work has also been presented at national meetings of ASCO, AACR, ASH, SIOG AND IASLC.
Dr. Langer is a Fellow in the American College of Physicians and a member of the American Society for Clinical Oncology (ASCO), the American Associated for Cancer Research (AACR), the International Association for the Study of Lung Cancer (IASLC). He has served as Vice-Chair for the Radiation Therapy Oncology Group (RTOG now NRG) and chairs it Medical Oncology Subcommittee. He also serves on the core Thoracic and Head and Neck Committees of both the Eastern Cooperative Group (ECOG) and RTOG (NRG).
10:00 — 10:40 am
10:40 — 11:20 am
Toxicity of Immune Checkpoint Inhibitors
Alex Adjei, MD
Alex A. Adjei is a Consultant in Oncology, Professor of Oncology and Professor of Pharmacology at Mayo Clinic and Mayo College of Medicine, in Rochester, MN. He is the Director of the Early Cancer Therapeutics and leader of the lung cancer program across all 3 Mayo Clinic sites. He is also co-Leader of the Developmental Therapeutics program at Mayo Cancer Center.
Dr Adjei’s research is focused on experimental therapeutics and clinical drug development. He received the first American Society of Clinical Oncology Drug Development Research Professorship 2012-2017, in recognition of his mentorship and his work in cancer drug development. He has authored 260 publications dealing primarily with preclinical pharmacology and phase I trials as well as novel therapies for lung cancer.
11:20 — 12:00 pm
Elizabeth Gore, MD
Medical College of Wisconsin
Dr. Elizabeth Gore is a Professor of Radiation Oncology at the Medical College of Wisconsin. Her clinical interests are lung and esophageal cancer.
She received her medical degree from the Medical College of Wisconsin and completed her residency and fellowship there. She is currently the Medical Director in the Department of Radiation Oncology at the Clement J. Zablocki Veterans Affairs Medical Center.
She is member of the Radiation Therapy Oncology Group (RTOG) Lung Committee, the International Association for the Study of Lung Cancer (IASLC), the American Society of Clinical Oncology (ASCO), and the American Society for Therapeutic Radiation Oncology (ASTRO). Dr. Gore has lectured and published extensively.